A critical breakthrough in cancer study is emerging with the use of mini-antibodies to restore mutated p53. This crucial cancer protector protein is frequently inactivated in various kinds of tumors, resulting https://socialnetworkadsinfo.com/story23691583/nanobodies-revive-the-p53-protein-the-potential-hope-for-malignant-management